Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.27 USD | +3.42% | +16.23% | -23.68% |
Apr. 15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
MarketScreener Editorial Features
Today on Wall Street: The start of a new phase | June 30, 2021 at 08:47 am EDT | |
ANALYST RECOMMENDATIONS : Apple, FedEx, Intellia Therapeutics, Reckitt Benckiser, XPO Logistics... | June 30, 2021 at 06:12 am EDT |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- MarketScreener Editorial Features